Dimensional Fund Advisors
WHWK

Dimensional Fund Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Dimensional Fund Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Buy
30,090
+1,449
+5% +$4.54K ﹤0.01% 3113
2025
Q4 		$69.3K Sell
28,641
-15,474
-35% -$35.5K ﹤0.01% 3190
2025
Q3 		$83.8K Sell
44,115
-26,634
-38% -$49K ﹤0.01% 3206
2025
Q2 		$132K Sell
70,749
-36,771
-34% -$64K ﹤0.01% 3160
2025
Q1 		$192K Buy
107,520
+71,925
+202% +$188K ﹤0.01% 3136
2024
Q4 		$112K Hold
35,595
– – ﹤0.01% 3231
2024
Q3 		$73.2K Sell
35,595
-61
-0.2% -$99 ﹤0.01% 3263
2024
Q2 		$52.2K Buy
35,656
+61
+0.2% +$113 ﹤0.01% 3311
2024
Q1 		$83.3K Hold
35,595
– – ﹤0.01% 3280
2023
Q4 		$72K Sell
35,595
-15,660
-31% -$65.7K ﹤0.01% 3312
2023
Q3 		$248K Sell
51,255
-23,437
-31% -$136K ﹤0.01% 3181
2023
Q2 		$511K Sell
74,692
-14,610
-16% -$114K ﹤0.01% 3061
2023
Q1 		$646K Buy
89,302
+60,438
+209% +$646K ﹤0.01% 2987
2022
Q4 		$370 Buy
+28,864
New +$377K ﹤0.01% 3097
2021
Q3 		– Sell
-1,026
Closed -$26K – 3539
2021
Q2 		$26K Hold
1,026
– – ﹤0.01% 3456
2021
Q1 		$20K Sell
1,026
-581
-36% -$13.4K ﹤0.01% 3406
2020
Q4 		$24K Buy
+1,607
New +$34.4K ﹤0.01% 3340

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Dimensional Fund Advisors's WHWK Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Whitehawk Therapeutics (WHWK) stake by 5.1% in Q1 2026, buying an estimated $4.54K and bringing the position to 30,090 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3113.

Dimensional Fund Advisors first reported a position in WHWK in Q4 2020 and has held it in 17 quarters since. The position peaked at $646K in Q1 2023. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Dimensional Fund Advisors held 30,090 shares of Whitehawk Therapeutics worth $104K as of Q1 2026.
  • Dimensional Fund Advisors bought 1,449 Whitehawk Therapeutics shares in Q1 2026, an estimated $4.54K.
  • Whitehawk Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3113 holding.
  • Dimensional Fund Advisors first reported a position in Whitehawk Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Whitehawk Therapeutics position peaked at $646K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.